These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7246572

  • 1. Prazosin and congestive heart failure: short- and long-term therapy.
    Rouleau JL, Warnica JW, Burgess JH.
    Am J Med; 1981 Jul; 71(1):147-52. PubMed ID: 7246572
    [Abstract] [Full Text] [Related]

  • 2. Influence of oral prazosin therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Chatterjee K, Rubin SA, Ports TA, Parmley WW.
    Am J Med; 1981 Jul; 71(1):140-6. PubMed ID: 7246571
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
    Sharpe DN, Coxon R.
    Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
    [Abstract] [Full Text] [Related]

  • 4. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)].
    Akamatsu T, Suzuki A, Yamamoto T, Takahashi S, Kimata S, Hirosawa K.
    Kokyu To Junkan; 1979 Sep; 27(9):991-7. PubMed ID: 538350
    [No Abstract] [Full Text] [Related]

  • 5. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
    Bertel O, Burkart F, Bühler FR.
    Am Heart J; 1981 May; 101(5):529-33. PubMed ID: 7223592
    [Abstract] [Full Text] [Related]

  • 6. [Usefulness of vasodilators in congestive cardiac insufficiency: studies with prazosin].
    Conti CR, Miles D, Mehta J.
    Cardiology; 1980 May; 66 Suppl 2():186-92. PubMed ID: 7285029
    [No Abstract] [Full Text] [Related]

  • 7. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA, Needham KE, Evenson MK, Amsterdam EE, Mason DT.
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [Abstract] [Full Text] [Related]

  • 8. Acute hemodynamic and long-term clinical effects of prazosin in the treatment of chronic congestive heart failure.
    von der Lippe G, Ohm OJ, Lund-Johansen P.
    Acta Med Scand; 1981 Jul; 210(3):213-6. PubMed ID: 7293839
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA, Miller RR, DeMaria AN, Maxwell KS, Neumann A, Mason DT.
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [Abstract] [Full Text] [Related]

  • 10. Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.
    Packer M, Medina N, Yushak M.
    J Am Coll Cardiol; 1986 Mar; 7(3):671-80. PubMed ID: 2869077
    [Abstract] [Full Text] [Related]

  • 11. Clinical and hemodynamic improvement of congestive heart failure by long-term vasodilator therapy with postjunctional alpha 1-adrenoceptor blockade.
    Bertel O, Bühler FR, Burkart F.
    J Cardiovasc Pharmacol; 1982 Mar; 4 Suppl 1():S181-6. PubMed ID: 6175837
    [Abstract] [Full Text] [Related]

  • 12. Serial hemodynamic studies during the treatment of congestive heart failure with isolated low-dose oral prazosin therapy.
    Reyns PR, Romney D, Desser KB, Benchimol A.
    Angiology; 1979 Dec; 30(12):850-5. PubMed ID: 533015
    [Abstract] [Full Text] [Related]

  • 13. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H, Sassa H, Oba M, Fukaya T, Okubo M, Niwa T, Matsui E.
    Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
    [Abstract] [Full Text] [Related]

  • 14. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE, Magorien RD, Triffon DW, Blanford MF, Unverferth DV, Leier CV.
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [Abstract] [Full Text] [Related]

  • 15. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
    Elkayam U, Lejemtel TH, Mathur M, Ribner HS, Frishman WH, Strom J, Sonnenblick EH.
    Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434
    [No Abstract] [Full Text] [Related]

  • 16. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH.
    N Engl J Med; 1986 Jun 12; 314(24):1547-52. PubMed ID: 3520315
    [Abstract] [Full Text] [Related]

  • 17. A review of the long-term effects of prazosin and hydralazine in chronic congestive heart failure.
    Rutishauser W.
    Eur Heart J; 1983 Jan 12; 4 Suppl A():149-52. PubMed ID: 6840121
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB, Williams RL, Ports TA, Baughman RA, Benet LZ, Parmley WW, Chatterjee K.
    Ann Intern Med; 1979 Sep 12; 91(3):345-9. PubMed ID: 475164
    [Abstract] [Full Text] [Related]

  • 19. The effects of prazosin in severe congestive heart failure. An echocardiographic study.
    Drăgulescu SI, Comşulea L, Streian C.
    Med Interne; 1984 Sep 12; 22(1):29-33. PubMed ID: 6710045
    [Abstract] [Full Text] [Related]

  • 20. Non-invasive radiocardiographic assessment of the effects of prazosin in congestive heart failure.
    Nakajima H, Yui Y, Kawashita K, Yoshida A, Kawai C.
    Jpn Circ J; 1982 May 12; 46(5):468-72. PubMed ID: 7077811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.